Related Experiment Video

Updated: Jul 7, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

Heme oxygenase: a target gene for anti-diabetic and obesity

N G Abraham1, P L Tsenovoy, J McClung

  • 1New York Medical College, Director of Gene Therapy, Room 527, Valhalla NY 10595, USA. NADER_ABRAHAM@NYMC.EDU

Current Pharmaceutical Design
|February 22, 2008
PubMed

Insights

Heme oxygenase-1 (HO-1) protects against oxidative stress. Upregulating HO-1 may offer new treatments for diabetes and obesity complications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pathophysiology

Background:

  • Heme oxygenase-1 (HO-1) is a key enzyme in oxidative stress regulation.
  • Diabetes and obesity are associated with increased oxidative injury.
  • The protective role of HO-1 in these conditions requires further elucidation.

Purpose of the Study:

  • To examine the role of increased HO-1 expression and activity in mitigating diabetes-related detrimental effects.
  • To review the mechanisms by which HO-1 exerts its protective functions.
  • To explore potential therapeutic strategies targeting HO-1.

Main Methods:

  • Literature review of studies investigating HO-1 in diabetes and obesity.
  • Analysis of the molecular mechanisms of HO-1 action.
  • Synthesis of current research on HO-1's impact on oxidative stress.

Main Results:

  • Increased HO-1 expression and activity demonstrate a protective effect against diabetes-induced oxidative damage.
  • HO-1 modulates pathways involved in inflammation and cellular protection.
  • Evidence suggests HO-1 can ameliorate metabolic dysfunction.

Conclusions:

  • HO-1 plays a significant role in combating oxidative stress in diabetes.
  • Targeting HO-1 offers a promising avenue for developing novel therapies.
  • Pharmacological and genetic interventions aimed at boosting HO-1 could manage diabetes and obesity complications.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...